Inventor
BAUMAN JOHN G
US25 patents
⚠️ This page may combine multiple inventors who share the name “BAUMAN JOHN G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING AG
12 patentsUS6207665B1Mar 27, 2001
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG89 citations98
US6555537B2Apr 29, 2003
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG24 citations92
US6534509B1Mar 18, 2003
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG19 citations92
US5602246AFeb 11, 1997
Process for the preparation of fludarabine or fludarabine phosphate from guanosine
SCHERING AG21 citations90
US5668270ASep 16, 1997
Process for the preparation of fludarabine or fludarabine phosphate from guanosine
SCHERING AG16 citations80
US6541476B1Apr 1, 2003
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG3 citations73
US7223798B2May 29, 2007
Lipoxin A4 analogs
SCHERING AG8 citations71
US5696255ADec 9, 1997
Process for the production of 2-fluoropurine derivatives
SCHERING AG2 citations61
US7268140B2Sep 11, 2007
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG0 citations52
US6977258B2Dec 20, 2005
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG0 citations52
US6972290B2Dec 6, 2005
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG0 citations52
US6573266B1Jun 3, 2003
Piperazine derivatives and their use as anti-inflammatory agents
SCHERING AG0 citations52
GRAYBUG VISION INC
8 patentsUS9808531B2Nov 7, 2017
Compounds and compositions for the treatment of ocular disorders
GRAYBUG VISION INC5 citations82
US9956302B2May 1, 2018
Compounds and compositions for the treatment of ocular disorders
GRAYBUG VISION INC2 citations71
US11548861B2Jan 10, 2023
Drugs and compositions for the treatment of ocular disorders
GRAYBUG VISION INC0 citations61
US10159747B2Dec 25, 2018
Compounds and compositions for the treatment of ocular disorders
GRAYBUG VISION INC1 citations61
US10117950B2Nov 6, 2018
Compounds and compositions for the treatment of ocular disorders
GRAYBUG VISION INC1 citations61
US10111964B2Oct 30, 2018
Compounds and compositions for the treatment of ocular disorders
GRAYBUG VISION INC1 citations61
US10098965B2Oct 16, 2018
Compounds and compositions for the treatment of ocular disorders
GRAYBUG VISION INC1 citations61
US10485876B2Nov 26, 2019
Compounds and compositions for the treatment of ocular disorders
GRAYBUG VISION INC0 citations51